# Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury

> **NCT05337774** · PHASE1 · TERMINATED · sponsor: **Life Molecular Imaging SA** · enrollment: 18 (actual)

## Conditions studied

- Mild Traumatic Brain Injury

## Interventions

- **DRUG:** [18F]PI-2620

## Key facts

- **NCT ID:** NCT05337774
- **Lead sponsor:** Life Molecular Imaging SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-07
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-04-30
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** study funding period ended March 2022
- **Last updated:** 2024-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05337774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05337774, "Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05337774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*